Alnylam Switzerland

Alnylam Switzerland

Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. 

Send an enquiry

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alnylam Switzerland
Alnylam Switzerland Grafenauweg 4 6300 Zug Switzerland
Get directions

CPD Subsectors

Pharmaceutical
Scientific Research
Medical
Region - Europe
Scientific Organisations